A few notable studies have investigated the alternative splicing events of immune-related genes in bladder cancer—for example, the study of Li et al. (113) identified significant differences in the alternative splicing of PTGER3 between bladder cancer tissues and healthy tissues using gene differential expression analysis (Figure 3). The gene discussed is PTGER3; the disease is urinary bladder carcinoma.